期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Production of mesenchymal stem cell derived-secretome as cell-free regenerative therapy and immunomodulation:A biomanufacturing perspective
1
作者 fuad gandhi torizal FRANSISCUS FIANO ANTHONY KERANS ANNISA KHUMAIRA 《BIOCELL》 SCIE 2022年第8期1885-1891,共7页
The potential of mesenchymal stem cells(MSCs)in regenerative medicine has been largely known due to their capability to induce tissue regeneration in vivo with minimum inflammation during implantation.This adult stem ... The potential of mesenchymal stem cells(MSCs)in regenerative medicine has been largely known due to their capability to induce tissue regeneration in vivo with minimum inflammation during implantation.This adult stem cell type exhibit unique features of tissue repair mechanism and immune modulation mediated by their secreted factors,called secretome.Recently,the utilization of secretome as a therapeutic agent provided new insight into cell-free therapy.Nevertheless,a sufficient amount of secretome is necessary to realize their applications for translational medicine which required a proper biomanufacturing process.Several factors related to their production need to be considered to produce a clinical-grade secretome as a biological therapeutic agent.This viewpoint highlights the current challenges and considerations during the biomanufacturing process of MSCs secretome. 展开更多
关键词 SECRETOME MSCS Culture system
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部